These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 39117091

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Role of chemotherapy in the management of advanced thymic tumors.
    Evans TL, Lynch TJ.
    Semin Thorac Cardiovasc Surg; 2005; 17(1):41-50. PubMed ID: 16104360
    [Abstract] [Full Text] [Related]

  • 23. Precise Diagnosis and Treatment of Thymic Epithelial Tumors Based on Molecular Biomarkers.
    Du J, Zhou XJ.
    Crit Rev Oncog; 2017; 22(5-6):507-514. PubMed ID: 29604928
    [Abstract] [Full Text] [Related]

  • 24. Avelumab plus axitinib in unresectable or metastatic type B3 thymomas and thymic carcinomas (CAVEATT): a single-arm, multicentre, phase 2 trial.
    Conforti F, Zucali PA, Pala L, Catania C, Bagnardi V, Sala I, Della Vigna P, Perrino M, Zagami P, Corti C, Stucchi S, Barberis M, Guerini-Rocco E, Di Venosa B, De Vincenzo F, Cordua N, Santoro A, Giaccone G, De Pas TM.
    Lancet Oncol; 2022 Oct; 23(10):1287-1296. PubMed ID: 36096156
    [Abstract] [Full Text] [Related]

  • 25. Systemic Therapy in Advanced Thymic Epithelial Tumors: Insights from the RYTHMIC Prospective Cohort.
    Merveilleux du Vignaux C, Dansin E, Mhanna L, Greillier L, Pichon E, Kerjouan M, Clément-Duchêne C, Mennecier B, Westeel V, Robert M, Quantin X, Zalcman G, Thiberville L, Lena H, Molina T, Calcagno F, Fournel P, Mazières J, Besse B, Girard N.
    J Thorac Oncol; 2018 Nov; 13(11):1762-1770. PubMed ID: 30138763
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Multimodality treatments in locally advanced stage thymomas.
    Hassan M, Seoud DE.
    Hematol Oncol Stem Cell Ther; 2009 Nov; 2(2):340-4. PubMed ID: 20118057
    [Abstract] [Full Text] [Related]

  • 28. Thymic Carcinomas-A Concise Multidisciplinary Update on Recent Developments From the Thymic Carcinoma Working Group of the International Thymic Malignancy Interest Group.
    Roden AC, Ahmad U, Cardillo G, Girard N, Jain D, Marom EM, Marx A, Moreira AL, Nicholson AG, Rajan A, Shepherd AF, Simone CB, Strange CD, Szolkowska M, Truong MT, Rimner A.
    J Thorac Oncol; 2022 May; 17(5):637-650. PubMed ID: 35227908
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Advanced stage thymomas and thymic carcinomas: results of multimodality treatments.
    Lucchi M, Ambrogi MC, Duranti L, Basolo F, Fontanini G, Angeletti CA, Mussi A.
    Ann Thorac Surg; 2005 Jun; 79(6):1840-4. PubMed ID: 15919267
    [Abstract] [Full Text] [Related]

  • 31. Comprehensive Genomic Profiling of 274 Thymic Epithelial Tumors Unveils Oncogenic Pathways and Predictive Biomarkers.
    Girard N, Basse C, Schrock A, Ramkissoon S, Killian K, Ross JS.
    Oncologist; 2022 Nov 03; 27(11):919-929. PubMed ID: 35749302
    [Abstract] [Full Text] [Related]

  • 32. Treatment of malignant thymoma.
    Giaccone G.
    Curr Opin Oncol; 2005 Mar 03; 17(2):140-6. PubMed ID: 15725919
    [Abstract] [Full Text] [Related]

  • 33. Thymoma and thymic carcinoma in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendations.
    Stachowicz-Stencel T, Synakiewicz A, Cornet M, Ferrari A, Garassino M, Masip JR, Julien R, Virgone C, Schneider DT, Brecht IB, Ben-Ami T, Bien E, Reguerre Y, Godzinski J, Bisogno G, Orbach D, Sarnacki S.
    Pediatr Blood Cancer; 2021 Jun 03; 68 Suppl 4():e29042. PubMed ID: 33881200
    [Abstract] [Full Text] [Related]

  • 34. Case report: Potential role of immunotherapy in thymic malignancies: a unique case of a durable and complete response upon an immune checkpoint inhibitor.
    Luciano A, Pietroluongo E, Ottaviano M, Grieco A, Peddio A, De Placido P, Servetto A, Mascolo M, Varricchio S, Bianco R, Palmieri G, Giuliano M.
    Front Immunol; 2024 Jun 03; 15():1423800. PubMed ID: 39026684
    [Abstract] [Full Text] [Related]

  • 35. [Thymic tumors].
    Girard N, Merveilleux Du Vignaux C, Molina T, Besse B, Rythmic R.
    Rev Prat; 2017 Apr 03; 67(4):430-434. PubMed ID: 30512890
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Neoadjuvant chemoradiotherapy for locally advanced thymic tumors: a phase II, multi-institutional clinical trial.
    Korst RJ, Bezjak A, Blackmon S, Choi N, Fidias P, Liu G, Marx A, Wright C, Mock S, Rutledge JR, Keshavjee S.
    J Thorac Cardiovasc Surg; 2014 Jan 03; 147(1):36-44, 46.e1. PubMed ID: 24139613
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Programmed Death-ligand 1 (PD-L1) Expression in Thymic Epithelial Tumors.
    Bedekovics J, Beke L, Mokanszki A, Szilagyi S, Mehes G.
    Appl Immunohistochem Mol Morphol; 2020 Jan 03; 28(1):1-9. PubMed ID: 30499814
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.